Cognevity’s dementia detection test receives FDA approval

Cognetivity Neurosciences has received notification from the US Food and Drug Administration (FDA) that its 510(k) submission for the CognICA Integrated Cognitive Assessment (ICA) has been reviewed and found to meet the requirements of regulations.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: